M Labinaz
Overview
Explore the profile of M Labinaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
So D, Wells G, McPherson R, Labinaz M, Le May M, Glover C, et al.
Pharmacogenomics J
. 2015 Apr;
16(1):71-8.
PMID: 25850030
Treatment of carriers of the CYP2C19*2 allele and ABCB1 TT genotype with clopidogrel is associated with increased ischemic complications after percutaneous coronary intervention (PCI). We sought to evaluate a pharmacogenomic...
2.
Al-Atassi T, Kimmaliardjuk D, Labinaz M, Dickie S, Rubens F
Perfusion
. 2014 Jan;
29(4):373-374.
PMID: 24447947
This case describes a novel approach to a safe redo-sternotomy in a patient presenting with an aortocutaneous fistula from a previous infected ascending aorta graft.
3.
Parkash R, deKemp R, Ruddy T, Kitsikis A, Hart R, Beauchesne L, et al.
J Nucl Cardiol
. 2004 Aug;
11(4):440-9.
PMID: 15295413
Background: Standard perfusion imaging may underestimate the extent of disease in 3-vessel coronary atherosclerosis. This study determined whether positron emission tomography quantification of perfusion reserve by use of rubidium 82...
4.
Scott N, Le May M, de Kemp R, Ruddy T, Labinaz M, Marquis J, et al.
Am J Cardiol
. 2001 Oct;
88(8):886-9, A6.
PMID: 11676954
No abstract available.
5.
OBrien E, Glover C, Labinaz M
J Invasive Cardiol
. 2001 Sep;
13(9):618-22.
PMID: 11533496
In-stent restenosis (ISR) is a growing problem that is without a practical, efficacious treatment strategy. The purpose of this study was to determine the acute outcome of 17 patients with...
6.
Dzavik V, Carere R, Mancini G, Cohen E, Catellier D, Anderson T, et al.
Am Heart J
. 2001 Aug;
142(2):301-8.
PMID: 11479470
Background: The Total Occlusion Study of Canada (TOSCA) is a multicenter, randomized trial evaluating the effect of stenting with > =1 heparin-coated stent on long-term patency after percutaneous coronary intervention...
7.
Tardiff B, Jennings L, Harrington R, Gretler D, Potthoff R, Vorchheimer D, et al.
Circulation
. 2001 Jul;
104(4):399-405.
PMID: 11468200
Background: Platelet deposition and aggregation are central to the pathogenesis of ischemic complications of acute coronary syndromes (ACS). Pharmacodynamic effects of the platelet glycoprotein IIb/IIIa antagonist eptifibatide have been delineated...
8.
Lacoursiere L, Millward S, Veinot J, Labinaz M
Can Assoc Radiol J
. 2001 May;
52(2):118-25.
PMID: 11339145
Objective: To evaluate the efficacy and safety of the Hydrolyser catheter for percutaneous treatment of massive pulmonary embolism in pigs. Materials And Methods: Twelve pigs, each weighing between 55 kg...
9.
Le May M, Labinaz M, Davies R, Marquis J, Laramee L, OBrien E, et al.
J Am Coll Cardiol
. 2001 Mar;
37(4):985-91.
PMID: 11263625
Objectives: We sought to directly compare primary stenting with accelerated tissue plasminogen activator (t-PA) in patients presenting with acute ST-elevation myocardial infarction (AMI). Background: Thrombolysis remains the standard therapy for...
10.
Labinaz M, Sketch Jr M, ELLIS S, Abramowitz B, Stebbins A, Pieper K, et al.
Am Heart J
. 2001 Mar;
141(3):469-77.
PMID: 11231447
Background: Patients with prior coronary bypass surgery with acute ST-segment elevation myocardial infarction (MI) pose an increasingly common clinical problem. We assessed the characteristics and outcomes of such patients undergoing...